ASTM E3418-23e1 PDF

Full title and description

ASTM E3418-23e1 — Standard Practice for Calculating Scientifically Justifiable Limits of Residues for Cleaning of Pharmaceutical and Medical Device Manufacturing Equipment and for Medical Devices. This practice provides procedures and calculation approaches for deriving health‑ and science‑based acceptance limits for chemical residues (including APIs, intermediates, cleaning agents, processing aids and other contaminants) on manufacturing equipment surfaces and on finished medical devices following cleaning.

Abstract

ASTM E3418-23e1 establishes a consistent, science‑ and risk‑based methodology for calculating safe, scientifically justifiable residue limits used in cleaning validation programs and product release for pharmaceutical, biopharmaceutical and medical device manufacturing. The practice emphasizes health‑based exposure limits (HBELs) and integrates concepts such as Acceptable Daily Exposure (ADE), quality risk management, statistical process control (SPC) and visual residue considerations. It is intended to support derivation of swab, rinse and visual limits that are defendable to regulators and consistent with other ASTM guidance documents.

General information

• Status: Current (active practice).
• Publication date: Original issue 2023 (designation E3418-23); amendment/e1 incorporated June 19, 2024 (published as E3418-23e1).
• Publisher: ASTM International.
• ICS / categories: 11.040.01 (Medical equipment in general); 11.080.20 (Disinfectants and antiseptics) — classification relevant to medical and pharmaceutical cleaning and residue control.
• Edition / version: E3418-23e1 (2023 edition with e1 amendment).
• Number of pages: 22 pages (typical published PDF length).

Scope

This practice provides step‑by‑step procedures for calculating safe and scientifically justifiable residue limits for use in cleaning validation and routine monitoring for pharmaceutical, biopharmaceutical and medical device manufacturing equipment and for cleaned medical devices. It applies to chemical residues remaining after all manufacturing and cleaning steps, and is intended to be used in conjunction with relevant guides on health‑based exposure limits, risk assessment and visual residue limits. The practice supports derivation of limits for swab and rinse samples, visual acceptance criteria, and process control limits, using a health‑ and risk‑based approach.

Key topics and requirements

• Derivation and application of health‑based exposure limits (HBELs) and Acceptable Daily Exposure (ADE) concepts for cleaning limits.
• Calculation procedures for swab, rinse and visual residue limits based on batch size, dose, surface area and exposure assumptions.
• Integration of quality risk management and toxicological considerations into limit setting.
• Use of statistical tools and statistical process control (SPC) to set performance‑based and process control limits.
• Guidance on applicability across pharmaceuticals, biologics, veterinary, over‑the‑counter products and medical devices.
• Consideration of different residue types (APIs, intermediates, cleaning agents, machining oils, etc.) and practical documentation requirements for cleaning validation.
• References to complementary ASTM guides and practices for HBEL derivation and visual residue assessment.

Typical use and users

This practice is used by cleaning validation engineers, quality assurance and quality control professionals, regulatory affairs specialists, toxicologists, process development scientists and medical device manufacturers. Typical applications include establishing cleaning acceptance criteria during validation, preparing validation protocols and reports, performing risk assessments for cross‑contamination, and defending residue limits to regulatory authorities.

Related standards

Commonly used together with ASTM guides and practices covering health‑based exposure limits and cleaning validation, including ASTM Guide E3219 (HBEL derivation), ASTM Practice/Guide E3106 (risk identification and analysis principles), and Practice E3263 (visual residue limits). The standard is also aligned conceptually with relevant regulatory guidance and standards used in toxicological and biological safety assessment for medical devices (for example, ISO biological evaluation series).

Keywords

cleaning limits, cleaning validation, residue limits, HBEL, ADE, health‑based exposure limit, risk‑based, science‑based, SPC, swab limits, rinse limits, visual residue, pharmaceutical, medical device, ASTM E3418-23e1

FAQ

Q: What is this standard?

A: ASTM E3418-23e1 is a practice for calculating scientifically justifiable residue limits for cleaning validation of pharmaceutical and medical device manufacturing equipment and for cleaned medical devices. It provides methodologies to derive health‑ and science‑based acceptance criteria.

Q: What does it cover?

A: It covers procedures to calculate swab, rinse and visual residue limits for a wide range of chemical residues (APIs, intermediates, cleaning agents, processing aids, etc.), guidance on applying HBEL/ADE concepts, and integration of risk management and statistical approaches to cleaning validation.

Q: Who typically uses it?

A: Cleaning validation teams, QA/QC, regulatory affairs, toxicologists, process development and manufacturing engineers in pharmaceutical, biopharmaceutical and medical device organizations use this practice for setting and documenting residue acceptance criteria.

Q: Is it current or superseded?

A: The practice is current. It was published as the 2023 edition (E3418-23) and includes the e1 amendment (designation E3418-23e1) incorporated in mid‑2024. Users should confirm they have the latest electronic or printed version before formal adoption.

Q: Is it part of a series?

A: Yes — it is intended to be used with related ASTM guidance and practices addressing HBEL derivation, cleaning validation risk analysis, and visual residue limits (for example, ASTM E3219, E3106 and E3263) and complements regulatory and industry guidance on cleaning limits and biological safety evaluations.

Q: What are the key keywords?

A: cleaning limits, cleaning validation, residue limits, HBEL, ADE, risk‑based, science‑based, SPC, swab limits, rinse limits, visual residue, pharmaceutical, medical device.